|
|Section2= |Section7= }} Dynemicin A is an anti-cancer enediyne drug. It displays properties which illustrate promise for innovative cancer treatments, but still requires further research. == History and background == Dynemicin A was first isolated from the soil in the Gujarat State of India. It was discovered to be the natural product of the indigenous bacteria ''Micromonospora chersina''. The natural product displays a bright purple color due to the anthraquinone chromophore structure within Dynemicin A. Initially this compound was isolated for its aesthetic properties as a dye, until further research demonstrated its anti-cancer properties. Shortly after the compound’s discovery, the Bristol-Myers Pharmaceutical Company first elucidated the structure in Japan. The structure of dynemicin A was determined from X-ray diffraction studies of triacetyldynemicin A; a closely related compound. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Dynemicin A」の詳細全文を読む スポンサード リンク
|